Form 4: Bicycle Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Kevin Lee, CHIEF EXECUTIVE OFFICER and a Director of Bicycle Therapeutics Plc, sold 7,805 shares of common stock on October 2, 2026.
Summary
- Open-market sale: disposed of 6,167 Ordinary Shares at $3.47 ($21,399) on October 2, 2026; holds 597,504 after (Direct).
- Open-market sale: disposed of 1,638 Ordinary Shares at $3.57 ($5,848) on October 5, 2026; holds 595,866 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $27,247 of stock on the open market.
Insider Transactions
Kevin Lee — Director, Officer (CHIEF EXECUTIVE OFFICER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Open-market sale | Ordinary Shares | 6,167 | $3 | $21.4K | 597,504 |
| 2026-10-05 | Open-market sale | Ordinary Shares | 1,638 | $4 | $5.8K | 595,866 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Open-market sale (6,167 shares) |
| 2026-10-05 | Open-market sale (1,638 shares) |
Keywords
insider transaction, Form 4, BCYC, BICYCLE THERAPEUTICS PLC, bearish, Kevin Lee
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.